Candidate Therapeutic Target For Pulmonary Arterial Hypertension Identified

I don't normally write about pre-clinical research but my friend and CardioExchange colleague John Ryan has been on a tear lately (he even won a Young Investigator award from the AHA last year) with some fascinating and potentially important research. Briefly, and, I hope, not too simply, Ryan's research may have uncovered a key mechanism underlying the pathogenesis of pulmonary arterial hypertension. And, if the research holds up, it may offer a new therapeutic target for this rare but deadly d...